NANOVIRICIDES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nanoviricides, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q2 2024.
  • Nanoviricides, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.36M, a 34% increase year-over-year.
  • Nanoviricides, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$8.29M, a 3.43% increase year-over-year.
  • Nanoviricides, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$8.29M, a 3.43% increase from 2023.
  • Nanoviricides, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.59M, a 5.94% decline from 2022.
  • Nanoviricides, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$8.11M, a 8.11% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$8.29M -$2.36M +$1.21M +34% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-27
Q1 2024 -$9.51M -$1.85M -$152K -8.91% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$9.36M -$2.11M -$370K -21.2% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$8.99M -$1.97M -$398K -25.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-05-15
Q2 2023 -$8.59M -$3.57M -$1.79M -101% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-27
Q1 2023 -$6.8M -$1.7M +$89.9K +5.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$6.89M -$1.75M +$176K +9.16% Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-15
Q3 2022 -$7.06M -$1.57M +$1.04M +39.9% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-15
Q2 2022 -$8.11M -$1.78M +$293K +14.1% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-13
Q1 2022 -$8.4M -$1.79M +$315K +15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$8.72M -$1.92M +$409K +17.6% Oct 1, 2021 Dec 31, 2021 10-Q 2023-05-15
Q3 2021 -$9.12M -$2.61M -$302K -13.1% Jul 1, 2021 Sep 30, 2021 10-Q 2023-05-15
Q2 2021 -$8.82M -$2.07M -$198K -10.6% Apr 1, 2021 Jun 30, 2021 10-K 2022-10-13
Q1 2021 -$8.62M -$2.11M +$5.98M +73.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$14.6M -$2.33M -$403K -20.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-05-16
Q3 2020 -$14.2M -$2.31M -$750K -48% Jul 1, 2020 Sep 30, 2020 10-Q 2022-05-16
Q2 2020 -$13.4M -$1.87M +$338K +15.3% Apr 1, 2020 Jun 30, 2020 10-K 2021-10-12
Q1 2020 -$13.8M -$8.08M -$5.94M -278% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.84M -$1.93M +$303K +13.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-05-14
Q3 2019 -$8.14M -$1.56M +$280K +15.2% Jul 1, 2019 Sep 30, 2019 10-Q 2021-05-14
Q2 2019 -$8.42M -$2.21M -$561K -34% Apr 1, 2019 Jun 30, 2019 10-K 2021-10-12
Q1 2019 -$7.86M -$2.14M -$29.9K -1.42% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-22
Q4 2018 -$7.83M -$2.23M +$566K +20.2% Oct 1, 2018 Dec 31, 2018 10-Q 2020-06-22
Q3 2018 -$8.4M -$1.84M +$164K +8.18% Jul 1, 2018 Sep 30, 2018 10-Q 2020-06-22
Q2 2018 -$8.56M -$1.65M +$907K +35.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-10-13
Q1 2018 -$9.47M -$2.11M +$1.03M +32.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$10.5M -$2.8M -$1.25M -80.9% Oct 1, 2017 Dec 31, 2017 10-Q 2019-05-15
Q3 2017 -$9.25M -$2.01M +$1.06M +34.5% Jul 1, 2017 Sep 30, 2017 10-Q 2019-05-15
Q2 2017 -$10.3M -$2.56M -$907K -55% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-23
Q1 2017 -$9.4M -$3.14M +$1.85M +37.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$11.3M -$1.55M +$1.23M +44.3% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 -$12.5M -$3.06M -$1.75M -134% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$10.7M -$1.65M -$733K -79.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-10-12
Q1 2016 -$9.99M -$4.99M -$4.74M -1889% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$5.25M -$2.78M -$894K -47.5% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$4.36M -$1.31M -$2.16M -253% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$2.2M -$918K +$6.08M +86.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 -$8.28M -$251K -$1.57M -119% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$6.71M -$1.88M -$518K -38% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 -$6.19M $852K +$7.41M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$13.6M -$7M -$4.82M -221% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-16
Q1 2014 -$8.78M $1.32M +$5.01M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$13.8M -$1.36M -$155K -12.8% Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-25
Q3 2013 -$13.6M -$6.56M -$4.76M -264% Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-02-23
Q2 2013 -$8.88M -$2.18M -$537K -32.6% Apr 1, 2013 Jun 30, 2013 10-K/A 2013-10-08
Q1 2013 -$8.34M -$3.68M -$1.65M -81.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$6.69M -$1.21M +$183K +13.1% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$6.87M -$1.8M -$664K -58.2% Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-18
Q2 2012 -$6.21M -$1.64M -$386K -30.7% Apr 1, 2012 Jun 30, 2012 10-K/A 2015-02-23
Q1 2012 -$5.82M -$2.03M +$515K +20.2% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-20
Q4 2011 -$6.34M -$1.39M +$184K +11.7% Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-02-22
Q3 2011 -$6.52M -$1.14M -$42.5K -3.87% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$6.48M -$1.26M Apr 1, 2011 Jun 30, 2011 10-K/A 2013-10-08
Q1 2011 -$2.55M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$1.58M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$1.1M Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.